CORRESP Filing
ImageneBio, Inc.
Date: Sept. 11, 2025 · CIK: 0001835579 · Accession: 0001193125-25-201427
AI Filing Summary & Sentiment
File numbers found in text: 333-290108
Show Raw Text
CORRESP 1 filename1.htm CORRESP ImageneBio, Inc. 12526 High Bluff Drive, Suite 345 San Diego, CA 92130 (858) 345-6265 September 11, 2025 V IA E DGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3010 Attn: Tyler Howes Re: ImageneBio, Inc. Registration Statement on Form S-1 File No. 333-290108 Acceleration Request Requested Date: Monday, September 15, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the “ Registration Statement ”) to become effective at 4:00 p.m. Eastern Time on Monday, September 15, 2025, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (858) 550-6090 or Asa Henin of Cooley LLP at (858) 550-6104. Sincerely, ImageneBio, Inc. By: /s/ Jotin Marango Jotin Marango, M.D., Ph.D. Chief Financial Officer and Corporate Secretary